Insulet | PODD - 営業利益

株価
177.18
毎日の変更
5.04 2.93%
毎月
-15.56%
毎年
-29.20%
Q2 予測
185.50




営業利益 変化する 日付
Abbott USD 1.85B 399M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD 66M 280.2M 2026-03
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.05B 190M 2026-03
Cardinal Health USD 861M 98M 2026-03
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
ICU Medical USD 26.09M 770K 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
J&J USD 6.62B 1.03B 2026-03
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 44.16M 10.04M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Solventum Corp USD 105M 1.58B 2025-12
Stryker USD 1.1B 867M 2026-03
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
West Pharmaceutical Services USD 177.1M 14.6M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03